• Home
  • News
  • Coins2Day 500
  • Tech
  • Finance
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
TechBrainstorm Health

St. Jude Medical Will Form a Cybersecurity Board After Heart Device Defect

By
Reuters
Reuters
Down Arrow Button Icon
By
Reuters
Reuters
Down Arrow Button Icon
October 17, 2016, 2:42 PM ET
The ticker and trading information for St. Jude Medical is displayed where the stock is traded on the floor of the New York Stock Exchange.
Photograph by Brendan McDermid—Reuters/File Photo

Medical-device maker St. Jude Medical said on Monday that it planned to set up a medical advisory board focused on cyber-security issues affecting patient care and safety.

St. Jude said in a statement that the group, known as the Cyber Security Medical Advisory Board, would provide advice on cyber security standards for medical devices.

The St. Paul, Minnesota-based company is establishing the group as the U.S. Food and Drug Administration investigates claims that St. Jude heart devices are riddled with defects that make them vulnerable to fatal cyber hacks.

The FDA launched that probe in August after short-seller Muddy Waters and cyber research firm MedSec Holdings said they had placed bets that St. Jude shares would fall after they discovered the alleged vulnerabilities.

“We take the cyber security of our devices very seriously and creating the Cyber Security Medical Advisory Board is one more demonstration of our ongoing commitment to advancing standards of patient care around the world without comprising safety and security,” St. Jude Chief Medical Officer Mark Carlson said in a statement.

Get Data Sheet, Coins2Day’s technology newsletter.

The board, whose membership has yet to be finalized, will work with technology experts at St. Jude Medical as well as external researchers to help “maintain and enhance cyber security and patient safety,” Carlson said.

An FDA representative said the agency had no immediate comment.

St. Jude (STJ) agreed in April to sell itself for $25 billion to Abbott Laboratories.

The company last week said it would recall some of its 400,000 implanted heart devices due to risk of premature battery depletion, a condition linked to two deaths in Europe.

About the Author
By Reuters
See full bioRight Arrow Button Icon
Rankings
  • 100 Best Companies
  • Coins2Day 500
  • Global 500
  • Coins2Day 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Leadership
  • Success
  • Tech
  • Asia
  • Europe
  • Environment
  • Coins2Day Crypto
  • Health
  • Retail
  • Lifestyle
  • Politics
  • Newsletters
  • Magazine
  • Features
  • Commentary
  • Mpw
  • CEO Initiative
  • Conferences
  • Personal Finance
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Coins2Day Brand Studio
  • Coins2Day Analytics
  • Coins2Day Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Coins2Day
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map

© 2025 Coins2Day Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Coins2Day Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.